Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
2.47
+0.03 (1.23%)
At close: Jun 29, 2022 4:00 PM
2.55
+0.08 (3.24%)
After-hours:
Jun 29, 2022 6:50 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Selling, General & Admin
|
30.04 | 21.36 | 7.58 | 1.95 | 0.67 |
| Research & Development
|
96.83 | 48.21 | 21.75 | 6.95 | 3.45 |
| Operating Expenses
|
126.87 | 69.57 | 29.33 | 8.9 | 4.12 |
| Operating Income
|
-126.87 | -69.57 | -29.33 | -8.9 | -4.12 |
| Interest Expense / Income
|
0 | 0 | 0 | 0 | 0.07 |
| Other Expense / Income
|
-1.28 | -2.32 | 5.93 | 0.03 | 0.42 |
| Pretax Income
|
-125.6 | -67.25 | -35.26 | -8.93 | -4.6 |
| Net Income
|
-125.6 | -67.25 | -35.26 | -8.93 | -4.6 |
| Net Income Common
|
-125.6 | -67.25 | -35.26 | -8.93 | -4.6 |
| Shares Outstanding (Basic)
|
36 | 33 | 2 | 2 | 2 |
| Shares Outstanding (Diluted)
|
36 | 33 | 2 | 2 | 2 |
| Shares Change
|
9.97% | 1485.31% | 2.83% | 4.91% | - |
| EPS (Basic)
|
-3.47 | -2.05 | -16.99 | -4.42 | -2.39 |
| EPS (Diluted)
|
-3.47 | -2.05 | -16.99 | -4.42 | -2.39 |
| Free Cash Flow Per Share
|
-2.84 | -1.59 | -11.90 | -4.23 | -1.26 |
| EBITDA
|
-125.39 | -67.2 | -35.21 | -8.89 | -4.51 |
| Depreciation & Amortization
|
0.21 | 0.05 | 0.05 | 0.04 | 0.02 |
| EBIT
|
-125.6 | -67.25 | -35.26 | -8.93 | -4.54 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).